Pomerantz Roger 4
4 · Indaptus Therapeutics, Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Pomerantz Roger
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-10+30,000→ 30,000 totalExercise: $0.33Exp: 2035-06-10→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable on June 10, 2026.